5-(2-hydroxyphenyl)furan-2-carbaldehyde

• 分子结构分类: 有机化合物 - 苯类化合物 - 酚类
• 英文名称: 5-(2-hydroxyphenyl)furan-2-carbaldehyde
• 英文别名: 5-(2-Hydroxyphenyl)-2-furaldehyde
• 化学式: C₁₁H₈O₃
• mdl: MFCD06802613
• 分子量: 188.183
• InChiKey: MTJXABYHDCRQSN-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.1
• 重原子数：
  14
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  50.4
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  5-(2-hydroxyphenyl)furan-2-carbaldehyde 在 甲醇 、 sodium tetrahydroborate 、 乙酰氯 作用下， 以 甲醇 为溶剂， 反应 17.0h， 生成 1-(5-(2-hydroxyphenyl)furan-2-yl)-N-(piperidin-4-ylmethyl)methanamine
  参考文献：
  名称：

  Antimalarial agents against both sexual and asexual parasites stages: structure-activity relationships and biological studies of the Malaria Box compound 1-[5-(4-bromo-2-chlorophenyl)furan-2-yl]-N-[(piperidin-4-yl)methyl]methanamine (MMV019918) and analogues

  摘要：

  Therapies addressing multiple stages of Plasmodium falciparum life cycle are highly desirable for implementing malaria elimination strategies. MMV019918 (1, 1-[5-(4-bromo-2-chlorophenyl)furan-2yl]-N-[(piperidin-4-yl)methyl]methanamine) was selected from the MMV Malaria Box for its dual activity against both asexual stages and gametocytes. In-depth structure-activity relationship studies and cytotoxicity evaluation led to the selection of 25 for further biological investigation. The potential transmission blocking activity of 25 versus P. falciparum was confirmed through the standard membrane feeding assay. Both 1 and 25 significantly prolonged atrioventricular conduction time in Langendorff-isolated rat hearts, and showed inhibitory activity of Ba2+ current through Ca(v)1.2 channels. An in silico target-fishing study suggested the enzyme phosphoethanolamine methyltransferase (PfPMT) as a potential target. However, compound activity against PfPMT did not track with the antiplasmodial activity, suggesting the latter activity relies on a different molecular target. Nevertheless, 25 showed interesting activity against PfPMT, which could be an important starting point for the identification of more potent inhibitors active against both sexual and asexual stages of the parasite. (C) 2018 Elsevier Masson SAS. All rights reserved.

  DOI：

  10.1016/j.ejmech.2018.03.024
• 作为产物：
  描述：

  5-甲醛基呋喃-2-硼酸 在 bis-triphenylphosphine-palladium(II) chloride 、 三氯化硼 作用下， 以 乙二醇二甲醚 、 乙醇 、 二氯甲烷 为溶剂， 反应 15.5h， 生成 5-(2-hydroxyphenyl)furan-2-carbaldehyde
  参考文献：
  名称：

  Antimalarial agents against both sexual and asexual parasites stages: structure-activity relationships and biological studies of the Malaria Box compound 1-[5-(4-bromo-2-chlorophenyl)furan-2-yl]-N-[(piperidin-4-yl)methyl]methanamine (MMV019918) and analogues

  摘要：

  Therapies addressing multiple stages of Plasmodium falciparum life cycle are highly desirable for implementing malaria elimination strategies. MMV019918 (1, 1-[5-(4-bromo-2-chlorophenyl)furan-2yl]-N-[(piperidin-4-yl)methyl]methanamine) was selected from the MMV Malaria Box for its dual activity against both asexual stages and gametocytes. In-depth structure-activity relationship studies and cytotoxicity evaluation led to the selection of 25 for further biological investigation. The potential transmission blocking activity of 25 versus P. falciparum was confirmed through the standard membrane feeding assay. Both 1 and 25 significantly prolonged atrioventricular conduction time in Langendorff-isolated rat hearts, and showed inhibitory activity of Ba2+ current through Ca(v)1.2 channels. An in silico target-fishing study suggested the enzyme phosphoethanolamine methyltransferase (PfPMT) as a potential target. However, compound activity against PfPMT did not track with the antiplasmodial activity, suggesting the latter activity relies on a different molecular target. Nevertheless, 25 showed interesting activity against PfPMT, which could be an important starting point for the identification of more potent inhibitors active against both sexual and asexual stages of the parasite. (C) 2018 Elsevier Masson SAS. All rights reserved.

  DOI：

  10.1016/j.ejmech.2018.03.024

文献信息

• Discovery of novel inhibitors of human phosphoglycerate dehydrogenase by activity-directed combinatorial chemical synthesis strategy
  作者：Xia Zhou、Yuping Tan、Kun Gou、Lei Tao、Yuan Luo、Yue Zhou、Zeping Zuo、Qingxiang Sun、Youfu Luo、Yinglan Zhao

  DOI：10.1016/j.bioorg.2021.105159

  日期：2021.10

  adopted activity-directed combinatorial chemical synthesis strategy to optimize this hit compound. Compound b36 was found to be the noncompetitive and the most promising one with IC50 values of 5.96 ± 0.61 μM against PHGDH. Compound b36 inhibited the proliferation of human breast cancer and ovarian cancer cells, reduced intracellular serine synthesis, damaged DNA synthesis, and induced cell cycle arrest

  丝氨酸是从头合成嘌呤和脱氧胸苷所必需的一碳单元的来源，在癌细胞的生长中起着至关重要的作用。磷酸甘油酸脱氢酶 (PHGDH) 催化丝氨酸从头生物合成中的第一个限速步骤，已成为治疗癌症的有希望的靶点。在这里，我们从基于酶促测定的内部小分子库的筛选中确定了H-G6作为潜在的 PHGDH 抑制剂。我们采用了活性导向的组合化学合成策略来优化这种命中化合物。发现化合物b36是非竞争性和最有前途的化合物，其对 PHGDH 的IC 50值为 5.96 ± 0.61 μM。化合物b36抑制人乳腺癌和卵巢癌细胞的增殖，减少细胞内丝氨酸合成，破坏DNA合成，并诱导细胞周期停滞。总的来说，我们的结果表明b36是一种新型的 PHGDH 抑制剂，它可能是一种有前景的调节丝氨酸合成途径的调节剂，并且可能是一种潜在的抗癌先导物，值得进一步探索。
• CYCLIC CARBOXYLIC ACID RHODANINE DERIVATIVES FOR THE TREATMENT AND PREVENTION OF TUBERCULOSIS
  申请人：Singh Jasbir

  公开号：US20100210577A1

  公开（公告）日：2010-08-19

  Disclosed are methods for the prevention or treatment of tuberculosis in a subject infected with Mycobacterium tuberculosis by administering rhodanine derivatives of formula (I), as well as some novel such compounds. Other embodiments are also disclosed.

  公开了用于预防或治疗感染了结核分枝杆菌的受试者的结核病的方法，通过给予公式(I)的罗丹宁衍生物，以及一些新颖的此类化合物。还公开了其他实施例。
• 1,5-Dideoxy-1,5-imino-D-glucitol Compounds
  申请人：Lin Chun-Hung

  公开号：US20100113519A1

  公开（公告）日：2010-05-06

  1,5-Dideoxy-1,5-imino-D-glucitol compounds as shown in the specification. Also disclosed is a method of treating a hexosaminidase-associated disease.

  规范中显示的1,5-二去氧-1,5-亚胺-D-葡萄糖醇化合物。还公开了一种治疗己糖氨基酸酶相关疾病的方法。
• Furan-2-ylmethylene Thiazolidinediones as Novel, Potent, and Selective Inhibitors of Phosphoinositide 3-Kinase γ
  作者：Vincent Pomel、Jasna Klicic、David Covini、Dennis D. Church、Jeffrey P. Shaw、Karen Roulin、Fabienne Burgat-Charvillon、Delphine Valognes、Montserrat Camps、Christian Chabert、Corinne Gillieron、Bernard Françon、Dominique Perrin、Didier Leroy、Denise Gretener、Anthony Nichols、Pierre Alain Vitte、Susanna Carboni、Christian Rommel、Matthias K. Schwarz、Thomas Rückle

  DOI：10.1021/jm0601598

  日期：2006.6.1

  Class I phosphoinositide 3-kinases (PI3Ks), in particular PI3K gamma, have become attractive drug targets for inflammatory and autoimmune diseases. Here, we disclose a novel series of furan-2-ylmethylene thiazolidinediones as selective, ATP-competitive PI3K gamma inhibitors. Structure-based design and X-ray crystallography of complexes formed by inhibitors bound to PI3K gamma identified key pharmacophore features for potency and selectivity. An acidic NH group on the thiazolidinedione moiety and a hydroxy group on the furan-2-yl-phenyl part of the molecule play crucial roles in binding to PI3K and contribute to class IB PI3K selectivity. Compound 26 (AS-252424), a potent and selective small-molecule PI3K gamma inhibitor emerging from these efforts, was further profiled in three different cellular PI3K assays and shown to be selective for class IB PI3K-mediated cellular effects. Oral administration of 26 in a mouse model of acute peritonitis led to a significant reduction of leukocyte recruitment.
• US8338465B2
  申请人：——

  公开号：US8338465B2

  公开（公告）日：2012-12-25